Literature DB >> 1965491

Prevalence of bacterial vaginosis and its association with genital infections, inflammation, and contraceptive methods in women attending sexually transmitted disease and primary health clinics.

H Moi1.   

Abstract

In an epidemiological survey of 2128 women attending a sexually transmitted diseases clinic for the first time and 200 attending two primary health clinics, 26% and 27% respectively were found to have bacterial vaginosis. The prevalence increased significantly with age, being diagnosed in 22.8% (326/1431) of women aged 14-24 years, and in 33.3% (232/697) of those aged greater than or equal to 25 years. Bacterial vaginosis was associated with gonorrhoea and with chlamydial infection, but was negatively associated with genital papillomavirus infection and yeast infection. Women using barrier contraceptives had a significantly lower prevalence of bacterial vaginosis than those using an intrauterine device or no contraceptive. Women less than or equal to 24 years old using oral contraceptives had a significantly lower prevalence of bacterial vaginosis than those not using contraceptives. Patients without gonorrhoea or chlamydial infection but with vaginal or urethral inflammatory signs had a significantly higher prevalence of bacterial vaginosis than those without inflammatory signs. These findings may have implications regarding complications associated with lower genital tract infections and may strengthen the hypothesis that bacterial vaginosis is a risk factor for pelvic inflammatory disease.

Entities:  

Keywords:  Adnexitis; Age Factors; Biology; Contraception; Contraceptive Methods; Contraceptive Usage; Demographic Factors; Developed Countries; Diseases; Europe; Examinations And Diagnoses; Family Planning; Genital Effects, Female; Genitalia; Genitalia, Female; Infections; Iud; Laboratory Examinations And Diagnoses; Laboratory Procedures; Measurement; Northern Europe; Oral Contraceptives; Pelvic Inflammatory Disease; Physiology; Population; Population Characteristics; Prevalence; Reproductive Tract Infections; Research Methodology; Risk Factors; Scandinavia; Sexually Transmitted Diseases; Sweden; Urogenital System; Vaginal Abnormalities

Mesh:

Year:  1990        PMID: 1965491     DOI: 10.1177/095646249000100203

Source DB:  PubMed          Journal:  Int J STD AIDS        ISSN: 0956-4624            Impact factor:   1.359


  33 in total

1.  Prevalence of Chlamydia trachomatis infections in women attending six women's healthcare units in Kaunas, Lithuania.

Authors:  M Domeika; R Butylkina; A Hallén; T Spukaite; V Juceviciute; D Morkunaite; R Jakutiene; V Paliuniene; J Barakauskiene; M Goberis
Journal:  Sex Transm Infect       Date:  2001-12       Impact factor: 3.519

2.  Gynecologic Complications of Bacterial Vaginosis: Fact or Fiction?

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

3.  Bacterial Vaginosis.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-02       Impact factor: 3.725

4.  Characteristics and pregnancy outcomes of pregnant women asymptomatic for bacterial vaginosis.

Authors:  Deborah B Nelson; Scarlett Bellamy; Bonnie A Clothier; George A Macones; Irving Nachamkin; Althea Ruffin; Lynne Allen-Taylor; Frank K Friedenberg
Journal:  Matern Child Health J       Date:  2007-06-02

5.  Is bacterial vaginosis a sexually transmitted infection?

Authors:  M C Morris; P A Rogers; G R Kinghorn
Journal:  Sex Transm Infect       Date:  2001-02       Impact factor: 3.519

6.  Humoral antibody to Mobiluncus curtisii, a potential serological marker for bacterial vaginosis.

Authors:  J R Schwebke; S C Morgan; S L Hillier
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

7.  Bacterial vaginosis: prevalence in an Italian population of asymptomatic pregnant women and diagnostic aspects.

Authors:  L Cristiano; S Rampello; C Noris; V Valota
Journal:  Eur J Epidemiol       Date:  1996-08       Impact factor: 8.082

8.  New concepts in the etiology of bacterial vaginosis.

Authors:  Jane R Schwebke
Journal:  Curr Infect Dis Rep       Date:  2009-03       Impact factor: 3.725

Review 9.  Current Treatment of Bacterial Vaginosis-Limitations and Need for Innovation.

Authors:  Catriona S Bradshaw; Jack D Sobel
Journal:  J Infect Dis       Date:  2016-08-15       Impact factor: 5.226

10.  Baseline survey of sexually transmitted infections in a cohort of female bar workers in Mbeya Region, Tanzania.

Authors:  G Riedner; M Rusizoka; O Hoffmann; F Nichombe; E Lyamuya; D Mmbando; L Maboko; P Hay; J Todd; R Hayes; M Hoelscher; H Grosskurth
Journal:  Sex Transm Infect       Date:  2003-10       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.